These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30306813)

  • 1. High intensity focused ultrasound treatment of adenomyosis: a comparative study.
    Guo Q; Xu F; Ding Z; Li P; Wang X; Gao B
    Int J Hyperthermia; 2018; 35(1):505-509. PubMed ID: 30306813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up.
    Haiyan S; Lin W; Shuhua H; Wang W
    Int J Hyperthermia; 2019; 36(1):1179-1185. PubMed ID: 31793356
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of high-intensity focused ultrasound combined with LNG-IUS for adenomyosis: a systematic review and meta-analysis.
    Zhao TT; Pang LL; Yang LL; Li RN; Fan LX; Wen Y
    Arch Gynecol Obstet; 2023 Aug; 308(2):351-362. PubMed ID: 35947146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis.
    Yang X; Zhang X; Lin B; Feng X; Aili A
    Int J Hyperthermia; 2019; 36(1):486-492. PubMed ID: 30994010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of high-intensity focused ultrasound combined with gonadotropin-releasing hormone agonist or combined with levonorgestrel-releasing intrauterine system for adenomyosis: A systematic review and meta-analysis.
    Lee YL; Bai YS; Yu MH; Chang FW; Wang YC; Chiang KJ; Wu GJ; Yin CS
    Taiwan J Obstet Gynecol; 2024 Jul; 63(4):492-499. PubMed ID: 39004475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study.
    Guo Y; Duan H; Cheng J; Zhang Y
    BJOG; 2017 Aug; 124 Suppl 3():7-11. PubMed ID: 28856862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of high intensity focused ultrasound ablation combined with GnRH-a and LNG-IUS for the treatment of adenomyosis].
    Ye MZ; Deng XL; Zhu XG; Xue M
    Zhonghua Fu Chan Ke Za Zhi; 2016 Sep; 51(9):643-649. PubMed ID: 27671043
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical evaluation of high-intensity focused ultrasound ablation combined with mifepristone and levonorgestrel-releasing intrauterine system to treat symptomatic adenomyosis.
    Zhu H; Ma Q; Dong G; Yang L; Li Y; Song S; Mu Y
    Int J Hyperthermia; 2023; 40(1):2161641. PubMed ID: 36586419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of HIFU combined with GnRH-a and LNG-IUS for adenomyosis patients who failed to respond to drug therapies: two-year follow-up results.
    Peng Y; Dai Y; Yu G; Yang X; Wen C; Jin P
    Int J Hyperthermia; 2021; 38(1):1271-1275. PubMed ID: 34423729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Intensity Focused Ultrasound Combined With Gonadotropin-Releasing Hormone Agonist or Levonorgestrel-Releasing Intrauterine System in Treating Dysmenorrhea of Severe Adenomyosis.
    Xu Y; Zhou Z; Wang H; Shao L; Liu G
    J Comput Assist Tomogr; 2021 Mar-Apr 01; 45(2):224-231. PubMed ID: 33661158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the treatment efficacies of HIFU, HIFU combined with GnRH-a, and HIFU combined with GnRH-a and LNG-IUS for adenomyosis: A systematic review and meta-analysis.
    Otgontuya A; Jeng CJ; Wu TN; Chuang LT; Shen J
    Taiwan J Obstet Gynecol; 2023 Mar; 62(2):226-238. PubMed ID: 36965889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of High-Intensity Focused Ultrasound Combined With GnRH-a for Adenomyosis: A Systematic Review and Meta-Analysis.
    Pang LL; Mei J; Fan LX; Zhao TT; Li RN; Wen Y
    Front Public Health; 2021; 9():688264. PubMed ID: 34485218
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
    Costanzi F; De Marco MP; Colombrino C; Ciancia M; Torcia F; Ruscito I; Bellati F; Frega A; Cozza G; Caserta D
    Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3432-3439. PubMed ID: 34002816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of high-intensity focused ultrasound combined with levonorgestrel-releasing intrauterine system on patients with adenomyosis.
    Cai Y; Sun Y; Xu F; Wu Y; Ren C; Hao X; Gao B; Cao Q
    Sci Rep; 2023 Jun; 13(1):9903. PubMed ID: 37336924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
    Park DS; Kim ML; Song T; Yun BS; Kim MK; Jun HS; Seong SJ
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):412-5. PubMed ID: 26384061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis.
    Zhang P; Song K; Li L; Yukuwa K; Kong B
    Med Princ Pract; 2013; 22(5):480-3. PubMed ID: 23796720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial.
    Shaaban OM; Ali MK; Sabra AM; Abd El Aal DE
    Contraception; 2015 Oct; 92(4):301-7. PubMed ID: 26071673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy and safety of levonorgestrel releasing intrauterine system in the treatment of adenomyosis: evidence mapping.
    Shi J; Gu Z; Wu Y; Li X; Zhang J; Zhang C; Yan H; Dai Y; Leng J
    Arch Gynecol Obstet; 2024 Jul; 310(1):55-67. PubMed ID: 38836931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of modified subtotal resection of adenomyosis combined with LNG-IUS and GnRH-a sequential therapy in severe adenomyosis: A case series.
    Qin Z; Dong Z; Tang H; Zhang S; Wang H; Bao M; Wei W; Shi R; Chen J; Xia B
    Front Surg; 2022; 9():914725. PubMed ID: 36061067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
    Kelekci S; Kelekci KH; Yilmaz B
    Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.